Product Detail
Acetyl L-Carnitine-13C3 Chloride
Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Acetyl L-Carnitine-13C3 Chloride Product Information
Acetyl L-Carnitine-13C3 Chloride is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-97845.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Acetyl L-Carnitine-13C3 Chloride
CAS No.
-
CAT No.
CS-T-97845
Molecular Formula
C6ยนยณC3H17ClNO4
Molecular Weight
241.67
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Acetyl L-Carnitine-13C3 Chloride
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"Acetyl L-Carnitine-13C3 Chloride is carbon-13 labeled Acetyl L-Carnitine Hydrochloride (A171990), which is a mitochondrial metabolite that helps to transport fatty acids into the mitochondria for energy (1). Acetyl-L-carnitine also upregulate metabotropic glutamate receptor 2 (mGlu2) via NF-?B p65 acetylation (2,3). It exhibits antidepressant and neuroprotective properties."
Synonyms
Acetyl L-Carnitine-13C3 Chloride
Application Notes
"Acetyl L-Carnitine-13C3 Chloride is carbon-13 labeled Acetyl L-Carnitine Hydrochloride (A171990), which is a mitochondrial metabolite that helps to transport fatty acids into the mitochondria for energy (1). Acetyl-L-carnitine also upregulate metabotropic glutamate receptor 2 (mGlu2) via NF-?B p65 acetylation (2,3). It exhibits antidepressant and neuroprotective properties."
References
"(1) Stephens, F. B., et al.: J Physiol. 581, 431 (2007)(2) Wang, S. M., et al.: J Psychiatr Res. 53, 30 (2014)(3) Cuccurazzu, B., et al.: Neuropsychopharmacology 38, 2220 (2013)"